Treatment of erosive pustular dermatosis: a systematic review of the literature
Importance Erosive pustular dermatosis (EPD) is a rare chronic inflammatory condition of the scalp and legs that is often difficult to manage. Currently, there are no treatment guidelines. Objective To systematically assess the existing literature on various treatment modalities and their efficacies...
Gespeichert in:
Veröffentlicht in: | International journal of dermatology 2020-07, Vol.59 (7), p.770-786 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 786 |
---|---|
container_issue | 7 |
container_start_page | 770 |
container_title | International journal of dermatology |
container_volume | 59 |
creator | Lee, Katrina H. Carley, Sama K. Kraus, Christina N. Mesinkovska, Natasha A. |
description | Importance
Erosive pustular dermatosis (EPD) is a rare chronic inflammatory condition of the scalp and legs that is often difficult to manage. Currently, there are no treatment guidelines.
Objective
To systematically assess the existing literature on various treatment modalities and their efficacies when used in the management of EPD.
Evidence review
We searched PubMed, Cochrane Libraries, Scopus, and clicnialtrial.gov databases for articles in the English language with no limited time frame. Emphasis was placed on articles that reported on treatment for EPD.
Findings
Of the 168 articles identified by the literature search, 92 met eligibility criteria and were included for qualitative analysis. Efficacious topical treatments included clobetasol, betamethasone, and tacrolimus. Ninety‐three and 88% of cases utilizing clobetasol and betamethasone respectively demonstrated improvement or resolution. All 32 cases utilizing tacrolimus reported improvement. Efficacious systemic treatments included oral steroids such as prednisone, methylprednisolone, and dexamethasone. Topical dapsone, photodynamic therapy, systemic steroids, cyclosporine, and oral zinc derivatives were also described with some success.
Conclusions and relevance
According to available data, limited solely to case reports and case series, potent topical steroids are an effective treatment option for EPD. Topical tacrolimus may also be considered in cases that require long‐term use or maintenance. Other treatment modalities shown to be successful based on high reported efficacy and low rates of recurrence after treatment include topical dapsone, systemic steroids, zinc derivatives, and cyclosporine. Further studies are needed to compare treatment modalities and to establish treatment protocols. |
doi_str_mv | 10.1111/ijd.14744 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2333931932</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2333931932</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3534-3db2e0ea958eac2d0084e6c81ca521f2e807fb34ef2623116773bab615e3a933</originalsourceid><addsrcrecordid>eNp1kD1PwzAQhi0EoqUw8AdQJBYY0vp8TpqwofJVVKlLd8tJLiJV0hTbadV_j0sLAxJeTmc9fs_3MHYNfAj-jKplMQQ5lvKE9QHjKJQxilPW5xwgTHmU9tiFtUvfogB5znoIKZcAUZ_NF4a0a2jlgrYMyLS22lCw7qzram2Cgkyjnb-0D4EO7M468n2VB4Y2FW33b9wHBXXlyGjXGbpkZ6WuLV0d64AtXp4Xk7dwNn-dTh5nYY4RyhCLTBAnnUYJ6VwUnCeS4jyBXEcCSkEJH5cZSipFLBAgHo8x01kMEaFOEQfs7hC7Nu1nR9apprI51bVeUdtZJRAx9Vui8OjtH3TZdmblP6eEhCjh4Gd76v5A5V6BNVSqtakabXYKuNpLVl6y-pbs2ZtjYpc1VPySP1Y9MDoA26qm3f9Javr-dIj8AhnihUc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2415801084</pqid></control><display><type>article</type><title>Treatment of erosive pustular dermatosis: a systematic review of the literature</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Lee, Katrina H. ; Carley, Sama K. ; Kraus, Christina N. ; Mesinkovska, Natasha A.</creator><creatorcontrib>Lee, Katrina H. ; Carley, Sama K. ; Kraus, Christina N. ; Mesinkovska, Natasha A.</creatorcontrib><description>Importance
Erosive pustular dermatosis (EPD) is a rare chronic inflammatory condition of the scalp and legs that is often difficult to manage. Currently, there are no treatment guidelines.
Objective
To systematically assess the existing literature on various treatment modalities and their efficacies when used in the management of EPD.
Evidence review
We searched PubMed, Cochrane Libraries, Scopus, and clicnialtrial.gov databases for articles in the English language with no limited time frame. Emphasis was placed on articles that reported on treatment for EPD.
Findings
Of the 168 articles identified by the literature search, 92 met eligibility criteria and were included for qualitative analysis. Efficacious topical treatments included clobetasol, betamethasone, and tacrolimus. Ninety‐three and 88% of cases utilizing clobetasol and betamethasone respectively demonstrated improvement or resolution. All 32 cases utilizing tacrolimus reported improvement. Efficacious systemic treatments included oral steroids such as prednisone, methylprednisolone, and dexamethasone. Topical dapsone, photodynamic therapy, systemic steroids, cyclosporine, and oral zinc derivatives were also described with some success.
Conclusions and relevance
According to available data, limited solely to case reports and case series, potent topical steroids are an effective treatment option for EPD. Topical tacrolimus may also be considered in cases that require long‐term use or maintenance. Other treatment modalities shown to be successful based on high reported efficacy and low rates of recurrence after treatment include topical dapsone, systemic steroids, zinc derivatives, and cyclosporine. Further studies are needed to compare treatment modalities and to establish treatment protocols.</description><identifier>ISSN: 0011-9059</identifier><identifier>EISSN: 1365-4632</identifier><identifier>DOI: 10.1111/ijd.14744</identifier><identifier>PMID: 31904115</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Administration, Cutaneous ; Administration, Oral ; Anti-Infective Agents - therapeutic use ; Betamethasone - therapeutic use ; Calcineurin Inhibitors - administration & dosage ; Calcineurin Inhibitors - therapeutic use ; Case reports ; Clobetasol - therapeutic use ; Cyclosporins ; Dapsone ; Dapsone - therapeutic use ; Derivatives ; Dexamethasone ; Dexamethasone - therapeutic use ; Diaminodiphenylsulfone ; Glucocorticoids - administration & dosage ; Glucocorticoids - therapeutic use ; Humans ; Inflammation ; Leg Dermatoses - drug therapy ; Literature reviews ; Methylprednisolone ; Methylprednisolone - therapeutic use ; Photochemotherapy ; Photodynamic therapy ; Prednisone ; Qualitative analysis ; Scalp ; Scalp Dermatoses - drug therapy ; Skin diseases ; Steroid hormones ; Steroids ; Tacrolimus ; Tacrolimus - administration & dosage ; Tacrolimus - therapeutic use ; Zinc</subject><ispartof>International journal of dermatology, 2020-07, Vol.59 (7), p.770-786</ispartof><rights>2020</rights><rights>2020 The International Society of Dermatology.</rights><rights>International Journal of Dermatology © 2020 International Society of Dermatology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3534-3db2e0ea958eac2d0084e6c81ca521f2e807fb34ef2623116773bab615e3a933</citedby><cites>FETCH-LOGICAL-c3534-3db2e0ea958eac2d0084e6c81ca521f2e807fb34ef2623116773bab615e3a933</cites><orcidid>0000-0003-1871-571X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fijd.14744$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fijd.14744$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31904115$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lee, Katrina H.</creatorcontrib><creatorcontrib>Carley, Sama K.</creatorcontrib><creatorcontrib>Kraus, Christina N.</creatorcontrib><creatorcontrib>Mesinkovska, Natasha A.</creatorcontrib><title>Treatment of erosive pustular dermatosis: a systematic review of the literature</title><title>International journal of dermatology</title><addtitle>Int J Dermatol</addtitle><description>Importance
Erosive pustular dermatosis (EPD) is a rare chronic inflammatory condition of the scalp and legs that is often difficult to manage. Currently, there are no treatment guidelines.
Objective
To systematically assess the existing literature on various treatment modalities and their efficacies when used in the management of EPD.
Evidence review
We searched PubMed, Cochrane Libraries, Scopus, and clicnialtrial.gov databases for articles in the English language with no limited time frame. Emphasis was placed on articles that reported on treatment for EPD.
Findings
Of the 168 articles identified by the literature search, 92 met eligibility criteria and were included for qualitative analysis. Efficacious topical treatments included clobetasol, betamethasone, and tacrolimus. Ninety‐three and 88% of cases utilizing clobetasol and betamethasone respectively demonstrated improvement or resolution. All 32 cases utilizing tacrolimus reported improvement. Efficacious systemic treatments included oral steroids such as prednisone, methylprednisolone, and dexamethasone. Topical dapsone, photodynamic therapy, systemic steroids, cyclosporine, and oral zinc derivatives were also described with some success.
Conclusions and relevance
According to available data, limited solely to case reports and case series, potent topical steroids are an effective treatment option for EPD. Topical tacrolimus may also be considered in cases that require long‐term use or maintenance. Other treatment modalities shown to be successful based on high reported efficacy and low rates of recurrence after treatment include topical dapsone, systemic steroids, zinc derivatives, and cyclosporine. Further studies are needed to compare treatment modalities and to establish treatment protocols.</description><subject>Administration, Cutaneous</subject><subject>Administration, Oral</subject><subject>Anti-Infective Agents - therapeutic use</subject><subject>Betamethasone - therapeutic use</subject><subject>Calcineurin Inhibitors - administration & dosage</subject><subject>Calcineurin Inhibitors - therapeutic use</subject><subject>Case reports</subject><subject>Clobetasol - therapeutic use</subject><subject>Cyclosporins</subject><subject>Dapsone</subject><subject>Dapsone - therapeutic use</subject><subject>Derivatives</subject><subject>Dexamethasone</subject><subject>Dexamethasone - therapeutic use</subject><subject>Diaminodiphenylsulfone</subject><subject>Glucocorticoids - administration & dosage</subject><subject>Glucocorticoids - therapeutic use</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Leg Dermatoses - drug therapy</subject><subject>Literature reviews</subject><subject>Methylprednisolone</subject><subject>Methylprednisolone - therapeutic use</subject><subject>Photochemotherapy</subject><subject>Photodynamic therapy</subject><subject>Prednisone</subject><subject>Qualitative analysis</subject><subject>Scalp</subject><subject>Scalp Dermatoses - drug therapy</subject><subject>Skin diseases</subject><subject>Steroid hormones</subject><subject>Steroids</subject><subject>Tacrolimus</subject><subject>Tacrolimus - administration & dosage</subject><subject>Tacrolimus - therapeutic use</subject><subject>Zinc</subject><issn>0011-9059</issn><issn>1365-4632</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kD1PwzAQhi0EoqUw8AdQJBYY0vp8TpqwofJVVKlLd8tJLiJV0hTbadV_j0sLAxJeTmc9fs_3MHYNfAj-jKplMQQ5lvKE9QHjKJQxilPW5xwgTHmU9tiFtUvfogB5znoIKZcAUZ_NF4a0a2jlgrYMyLS22lCw7qzram2Cgkyjnb-0D4EO7M468n2VB4Y2FW33b9wHBXXlyGjXGbpkZ6WuLV0d64AtXp4Xk7dwNn-dTh5nYY4RyhCLTBAnnUYJ6VwUnCeS4jyBXEcCSkEJH5cZSipFLBAgHo8x01kMEaFOEQfs7hC7Nu1nR9apprI51bVeUdtZJRAx9Vui8OjtH3TZdmblP6eEhCjh4Gd76v5A5V6BNVSqtakabXYKuNpLVl6y-pbs2ZtjYpc1VPySP1Y9MDoA26qm3f9Javr-dIj8AhnihUc</recordid><startdate>202007</startdate><enddate>202007</enddate><creator>Lee, Katrina H.</creator><creator>Carley, Sama K.</creator><creator>Kraus, Christina N.</creator><creator>Mesinkovska, Natasha A.</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1871-571X</orcidid></search><sort><creationdate>202007</creationdate><title>Treatment of erosive pustular dermatosis: a systematic review of the literature</title><author>Lee, Katrina H. ; Carley, Sama K. ; Kraus, Christina N. ; Mesinkovska, Natasha A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3534-3db2e0ea958eac2d0084e6c81ca521f2e807fb34ef2623116773bab615e3a933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Administration, Cutaneous</topic><topic>Administration, Oral</topic><topic>Anti-Infective Agents - therapeutic use</topic><topic>Betamethasone - therapeutic use</topic><topic>Calcineurin Inhibitors - administration & dosage</topic><topic>Calcineurin Inhibitors - therapeutic use</topic><topic>Case reports</topic><topic>Clobetasol - therapeutic use</topic><topic>Cyclosporins</topic><topic>Dapsone</topic><topic>Dapsone - therapeutic use</topic><topic>Derivatives</topic><topic>Dexamethasone</topic><topic>Dexamethasone - therapeutic use</topic><topic>Diaminodiphenylsulfone</topic><topic>Glucocorticoids - administration & dosage</topic><topic>Glucocorticoids - therapeutic use</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Leg Dermatoses - drug therapy</topic><topic>Literature reviews</topic><topic>Methylprednisolone</topic><topic>Methylprednisolone - therapeutic use</topic><topic>Photochemotherapy</topic><topic>Photodynamic therapy</topic><topic>Prednisone</topic><topic>Qualitative analysis</topic><topic>Scalp</topic><topic>Scalp Dermatoses - drug therapy</topic><topic>Skin diseases</topic><topic>Steroid hormones</topic><topic>Steroids</topic><topic>Tacrolimus</topic><topic>Tacrolimus - administration & dosage</topic><topic>Tacrolimus - therapeutic use</topic><topic>Zinc</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, Katrina H.</creatorcontrib><creatorcontrib>Carley, Sama K.</creatorcontrib><creatorcontrib>Kraus, Christina N.</creatorcontrib><creatorcontrib>Mesinkovska, Natasha A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Katrina H.</au><au>Carley, Sama K.</au><au>Kraus, Christina N.</au><au>Mesinkovska, Natasha A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of erosive pustular dermatosis: a systematic review of the literature</atitle><jtitle>International journal of dermatology</jtitle><addtitle>Int J Dermatol</addtitle><date>2020-07</date><risdate>2020</risdate><volume>59</volume><issue>7</issue><spage>770</spage><epage>786</epage><pages>770-786</pages><issn>0011-9059</issn><eissn>1365-4632</eissn><abstract>Importance
Erosive pustular dermatosis (EPD) is a rare chronic inflammatory condition of the scalp and legs that is often difficult to manage. Currently, there are no treatment guidelines.
Objective
To systematically assess the existing literature on various treatment modalities and their efficacies when used in the management of EPD.
Evidence review
We searched PubMed, Cochrane Libraries, Scopus, and clicnialtrial.gov databases for articles in the English language with no limited time frame. Emphasis was placed on articles that reported on treatment for EPD.
Findings
Of the 168 articles identified by the literature search, 92 met eligibility criteria and were included for qualitative analysis. Efficacious topical treatments included clobetasol, betamethasone, and tacrolimus. Ninety‐three and 88% of cases utilizing clobetasol and betamethasone respectively demonstrated improvement or resolution. All 32 cases utilizing tacrolimus reported improvement. Efficacious systemic treatments included oral steroids such as prednisone, methylprednisolone, and dexamethasone. Topical dapsone, photodynamic therapy, systemic steroids, cyclosporine, and oral zinc derivatives were also described with some success.
Conclusions and relevance
According to available data, limited solely to case reports and case series, potent topical steroids are an effective treatment option for EPD. Topical tacrolimus may also be considered in cases that require long‐term use or maintenance. Other treatment modalities shown to be successful based on high reported efficacy and low rates of recurrence after treatment include topical dapsone, systemic steroids, zinc derivatives, and cyclosporine. Further studies are needed to compare treatment modalities and to establish treatment protocols.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>31904115</pmid><doi>10.1111/ijd.14744</doi><tpages>17</tpages><orcidid>https://orcid.org/0000-0003-1871-571X</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0011-9059 |
ispartof | International journal of dermatology, 2020-07, Vol.59 (7), p.770-786 |
issn | 0011-9059 1365-4632 |
language | eng |
recordid | cdi_proquest_miscellaneous_2333931932 |
source | MEDLINE; Access via Wiley Online Library |
subjects | Administration, Cutaneous Administration, Oral Anti-Infective Agents - therapeutic use Betamethasone - therapeutic use Calcineurin Inhibitors - administration & dosage Calcineurin Inhibitors - therapeutic use Case reports Clobetasol - therapeutic use Cyclosporins Dapsone Dapsone - therapeutic use Derivatives Dexamethasone Dexamethasone - therapeutic use Diaminodiphenylsulfone Glucocorticoids - administration & dosage Glucocorticoids - therapeutic use Humans Inflammation Leg Dermatoses - drug therapy Literature reviews Methylprednisolone Methylprednisolone - therapeutic use Photochemotherapy Photodynamic therapy Prednisone Qualitative analysis Scalp Scalp Dermatoses - drug therapy Skin diseases Steroid hormones Steroids Tacrolimus Tacrolimus - administration & dosage Tacrolimus - therapeutic use Zinc |
title | Treatment of erosive pustular dermatosis: a systematic review of the literature |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T22%3A03%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20erosive%20pustular%20dermatosis:%20a%20systematic%20review%20of%20the%20literature&rft.jtitle=International%20journal%20of%20dermatology&rft.au=Lee,%20Katrina%20H.&rft.date=2020-07&rft.volume=59&rft.issue=7&rft.spage=770&rft.epage=786&rft.pages=770-786&rft.issn=0011-9059&rft.eissn=1365-4632&rft_id=info:doi/10.1111/ijd.14744&rft_dat=%3Cproquest_cross%3E2333931932%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2415801084&rft_id=info:pmid/31904115&rfr_iscdi=true |